Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

The company, which is headquartered in Bremen, Germany, was founded in 1985 and is a second-generation family business. The company specializes in grinding down particles used in pharmaceuticals ...

An employee shows processed flowers of cannabis (marijuana) at the production site of German ... [+] pharmaceutical company Demecan for medical cannabis in Ebersbach near Dresden, eastern Germany ...

The company is reportedly seen as an attractive acquisition target due to its diversified operations across two segments.

Germany’s pharmaceutical packaging market is a critical segment of the country’s broader pharmaceutical industry, which is one of the largest in Europe. The demand for innovative, safe, and ...

E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...

~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to <18 Years of Age with ...

Germany: The Medicinal Research Act ... The permission for pharmaceutical companies to negotiate confidential reimbursement prices for innovative drugs under specific conditions.

Gerresheimer, a German manufacturer specialising in packaging for pharmaceuticals and cosmetics, is reportedly considering a potential sale. The company has engaged advisors to assess interest ...